Radian Group Inc (RDN) 10.20 $RDN Stock Updates on

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Radian Group Inc (RDN) 10.20 $RDN

Stock Updates on Property & Casualty Insurance - XL Group, Radian Group, The Hartford Financial Services Group, and MBIA Inc.
PR Newswire - Thu Jun 23, 7:25AM CDT
On Wednesday, June 22, 2016, the NASDAQ Composite ended the trading session at 4,833.32, down 0.22%; the Dow Jones Industrial Average edged 0.27% lower to finish at 17,780.83; and the S&P 500 closed at 2,085.45, down 0.17%. Stock-Callers.com has initiated coverage on the following equities: XL Group PLC (NYSE: XL), Radian Group Inc. (NYSE: RDN), The Hartford Financial Services Group Inc. (NYSE: HIG), and MBIA Inc. (NYSE: MBI). Learn more about these stocks by accessing their free trade alerts at:
MBI: 6.55 (-0.50), RDN: 10.20 (-0.59), HIG: 42.67 (-2.29), XL: 31.42 (-1.86)

Watch for Radian to Potentially Rebound After Falling 1.37% Yesterday
Comtex SmarTrend(R) - Tue Jun 21, 4:18PM CDT
Radian (NYSE:RDN) traded in a range yesterday that spanned from a low of $9.86 to a high of $10.29. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $10.18 on volume of 2.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
RDN: 10.20 (-0.59)

February 2017 Options Now Available For Radian Group (RDN)
DividendChannel.com - Mon Jun 20, 9:48AM CDT
Investors in Radian Group, Inc. saw new options begin trading today, for the February 2017 expiration.
RDN: 10.20 (-0.59)

Radian Group's Mortgage Insurance Profile to Drive Growth
Zacks Equity Research - Zacks Investment Research - Mon Jun 06, 8:54AM CDT
On Jun 6, 2016, we issued an updated research report on Radian Group Inc. (RDN).
FFG: 57.93 (-4.12), RDN: 10.20 (-0.59), JRVR: 33.22 (-0.54)

Radian CFO to Participate at the Keefe, Bruyette & Woods Mortgage Finance Conference
BusinessWire - Thu May 26, 5:30AM CDT
Radian Group Inc. (NYSE: RDN) announced today that Frank Hall, chief financial officer, will be participating in a fireside chat at the Keefe, Bruyette & Woods 2016 Mortgage Finance Conference, which is being held at The Westin Grand Central hotel in New York City on Wednesday, June 1, 2016 at 10:00 a.m. Eastern time. The fireside chat will be webcast live and accessible by visiting http://wsw.com/webcast/kbw33/rdn or Radian's website at http://www.radian.biz/page?name=Webcasts.
RDN: 10.20 (-0.59)

Radian CEO S.A. Ibrahim to Retire in December 2017
BusinessWire - Tue May 17, 3:41PM CDT
Radian Group Inc. today announced that Chief Executive Officer S.A. Ibrahim, 64, informed the company's Board of Directors of his intention to retire at the end of his contract in December 2017. In keeping with Radian's succession planning process, the Board has appointed a special committee to commence a search for his successor. The committee has employed the assistance of Spencer Stuart, a leading executive recruitment firm, and will take into consideration internal as well as external candidates.
RDN: 10.20 (-0.59)

Clayton Holdings Receives Industry's First Ranking From Morningstar As RMBS Deal Agent And Representation And Warranty Reviewer
PR Newswire - Fri May 13, 8:00AM CDT
Clayton Holdings LLC, a leading provider of loan due diligence, surveillance, REO management, consulting, valuation, title and settlement services to the mortgage industry, announced today that Morningstar Credit Ratings, LLC has ranked the company as both a Residential Mortgage Backed Securities (RMBS) Deal Agent and as a Residential Representation and Warranty Reviewer. In both categories, Clayton was ranked MOR RV2 with a forecast of "Stable."
RDN: 10.20 (-0.59)

Radian Stockholders at Annual Meeting Re-elect Directors, Approve Executive Compensation and All Other Proposals; Company Declares Regular Quarterly Dividend on Common Stock
BusinessWire - Wed May 11, 3:30PM CDT
Radian Group Inc. announced today that its stockholders re-elected ten directors, who serve one-year terms and are re-elected annually. The company's stockholders approved all proposals recommended by the board of directors and presented for vote at Radian's 2016 Annual Meeting, including an advisory proposal on Radian's executive compensation and a re-approval of Radian's tax benefit preservation strategy.
RDN: 10.20 (-0.59)

Morningstar Credit Ratings Publishes First "Deal Agent" Ranking for Newly-Created Oversight Role in U.S. Residential Mortgage-Backed Securities Market
PR Newswire - Tue May 10, 10:52AM CDT
Morningstar Credit Ratings, LLC today announced it assigned two new vendor rankings for the recently created roles of Deal Agent and Representation and Warranty Reviewer in the residential mortgage-backed securities (RMBS) market. Morningstar assigned its MOR RV2 residential vendor rankings to Clayton Holdings, LLC, a wholly owned subsidiary of Radian Group Inc., a global provider of mortgage and real estate market risk-management solutions.
RDN: 10.20 (-0.59), MORN: 79.14 (-2.07)

Cigna (CI) Beats on Q1 Earnings & Revenues, Revises View
Zacks Equity Research - Zacks Investment Research - Fri May 06, 10:06AM CDT
Cigna Corp. (CI) reported first-quarter 2016 operating net earnings of $2.32 per share that comfortably beat the Zacks Consensus Estimate of $2.17 by 6.9%.
CI: 128.03 (-1.72), RDN: 10.20 (-0.59), AIZ: 83.66 (-2.92), MTG: 5.91 (-0.42)

The Zacks Analyst Blog Highlights: Fiat Chrysler Automobiles, Transocean Partners, Mallinckrodt Public Limited, Radian Group and Owens-Illinois
Zacks Equity Research - Zacks Investment Research - Fri May 06, 8:30AM CDT
The Zacks Analyst Blog Highlights: Fiat Chrysler Automobiles, Transocean Partners, Mallinckrodt Public Limited, Radian Group and Owens-Illinois
MNK: 56.24 (-2.48), RIGP: 12.33 (-0.31), RDN: 10.20 (-0.59), OI: 18.01 (-1.79), FCAU: 6.30 (-0.89)

MetLife (MET) Misses Q1 Earnings and Revenue Estimates
Zacks Equity Research - Zacks Investment Research - Thu May 05, 10:47AM CDT
MetLife, Inc.'s (MET) first-quarter 2016 earnings of $1.31 per share missed the Zacks Consensus Estimate of $1.39 by 5.8%.
RDN: 10.20 (-0.59), AIZ: 83.66 (-2.92), MET: 39.60 (-4.57), MTG: 5.91 (-0.42)

5 High Earnings Yield Stocks for Rich Rewards
Zacks Equity Research - Zacks Investment Research - Thu May 05, 10:39AM CDT
You can use the Earnings Yield to compare a stock with other stocks and with fixed income securities.
MNK: 56.24 (-2.48), RIGP: 12.33 (-0.31), RDN: 10.20 (-0.59), OI: 18.01 (-1.79), FCAU: 6.30 (-0.89)

Prudential (PRU) Q1 Earnings Miss, Down Y/Y on Low Revenues
Zacks Equity Research - Zacks Investment Research - Thu May 05, 10:16AM CDT
Prudential Financial, Inc. (PRU) reported first-quarter 2016 after tax adjusted operating income of $2.18 per share that missed the Zacks Consensus Estimate by 8.4%.
RDN: 10.20 (-0.59), AIZ: 83.66 (-2.92), PRU: 71.31 (-5.64), MTG: 5.91 (-0.42)

Genworth (GNW) Q1 Earnings Beat Estimates, Decline Y/Y
Zacks Equity Research - Zacks Investment Research - Fri Apr 29, 10:04AM CDT
Genworth Financial, Inc. (GNW) reported first-quarter 2016 net operating income of 21 cents per share, which handily beat the Zacks Consensus Estimate of 14 cents per share by 50%.
RDN: 10.20 (-0.59), AIZ: 83.66 (-2.92), MTG: 5.91 (-0.42), GNW: 3.05 (-0.31)

CNO Financial (CNO) Q1 Earnings Miss, Revenues Surpass
Zacks Equity Research - Zacks Investment Research - Thu Apr 28, 10:24AM CDT
CNO Financial Group, Inc.'s (CNO) first-quarter 2016 net operating earnings of 27 cents per share missed the Zacks Consensus Estimate by 15.6%.
RDN: 10.20 (-0.59), AIZ: 83.66 (-2.92), CNO: 17.68 (-1.58), MTG: 5.91 (-0.42)

Radian Group (RDN) Q1 Earnings, Revenues Beat Estimates
Zacks Equity Research - Zacks Investment Research - Thu Apr 28, 4:50AM CDT
Radian Group Inc. (RDN) reported first-quarter 2016 operating income of 37 cents per share, beating the Zacks Consensus Estimate by 23% and improving 5.7% year over year.
RDN: 10.20 (-0.59), AIZ: 83.66 (-2.92), CNO: 17.68 (-1.58), MTG: 5.91 (-0.42)

Radian beats 1Q profit forecasts
Automated Insights - Wed Apr 27, 5:47AM CDT
PHILADELPHIA (AP) _ Radian Group Inc. (RDN) on Wednesday reported first-quarter earnings of $66.2 million.
RDN: 10.19 (-0.60)

Radian Announces First Quarter 2016 Financial Results
BusinessWire - Wed Apr 27, 5:36AM CDT
-- Adjusted pretax operating income of $130 million --
RDN: 10.19 (-0.60)

Genworth (GNW) Q1 Earnings: Surprise in Store for Stock?
Zacks Equity Research - Zacks Investment Research - Tue Apr 26, 5:35PM CDT
Genworth Financial, Inc. (GNW) is scheduled to report first-quarter results after the closing bell on Apr 28. Let's see how things are shaping up for this announcement.
RDN: 10.19 (-0.60), PRU: 71.31 (-5.64), LNC: 38.76 (-5.61), GNW: 3.05 (-0.31)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 34

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 35

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 24

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 26

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 37

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 35

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading

Top 5 Most Recently Viewed Articles

Man Group PLC Highlights Its Strategic Disclosures on Tritax REIT

Updated Category News Views 148

Strategic Position Disclosure by Man Group PLC Man Group PLC is actively sharing its significant interests in the securities market, particularly focusing on its involvement with Tritax Big Box REIT plc. As a key player in the investment landscape, this disclosure marks an important step for the company regarding its strategic holdings. Key Information Pertaining to the...

Continue Reading
TalentLMS and Epignosis Lead the Way in GDPR Compliance

Updated Category News Views 720

TalentLMS and Epignosis Set the Standard for GDPR Compliance TalentLMS, along with its parent company Epignosis, has continuously led the way in providing a fully compliant Learning Management System (LMS) with regards to the General Data Protection Regulation (GDPR). Recent developments affirm that TalentLMS remains the only LMS globally to uphold its commitment to this...

Continue Reading
Zillow and Esusu Forge New Path to Boost Renters' Credit Scores

Updated Category News Views 283

Building Credit for Renters with Zillow and Esusu The recent collaboration between Zillow and Esusu marks a significant step towards empowering renters across the country to build their credit. This partnership allows any renter to report their on-time rent payments, significantly enhancing their credit profiles, for just $20 a year. How the Partnership Works Starting...

Continue Reading
iCrowdNewswire Leverages DeepL for Enhanced Global Communication

Updated Category News Views 121

iCrowdNewswire Enhances Multilingual Capabilities iCrowdNewswire, a prominent international press release distribution company, has embarked on a transformative journey to improve its multilingual services through the introduction of the DeepL API. The integration of DeepL's cutting-edge language AI technology has significantly boosted iCrowdNewswire’s ability to...

Continue Reading
Celebrating Excellence: Top Surgeons Recognized in Endocrine Care

Updated Category News Views 82

Exceptional Recognition for Leading Surgeons in Endocrine Surgery Dr. Jim Norman and Dr. Gary Clayman Acknowledged as Premier Specialists The Hospital for Endocrine Surgery is proud to announce that two of its distinguished surgeons, Dr. Jim Norman and Dr. Gary Clayman, have been honored in the prestigious Castle Connolly Top Doctors list for 2025. This remarkable...

Continue Reading